文献速递脑血管病认知障碍与痴呆

脂蛋白(a)水平对缺血性卒中与阿尔茨海默病的因果效应:孟德尔随机化研究

Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer Disease: A Mendelian Randomization Study.
PubMed 文献 · Stroke · 2019-10-10

本研究采用两样本孟德尔随机化方法,以9个与Lp(a)浓度相关的单核苷酸多态性为工具变量,分析遗传预测的Lp(a)水平与缺血性卒中及其亚型、阿尔茨海默病的因果关联。结果显示,遗传预测的Lp(a)每升高1个标准差(对数转换)与大面积动脉粥样硬化性卒中风险增加相关,与小血管卒中及阿尔茨海默病风险降低相关,而与总缺血性卒中及心源性栓塞性卒中无显著关联。

要点

  • 遗传预测的Lp(a)升高增加大动脉粥样硬化性卒中风险(OR 1.20)。
  • 遗传预测的Lp(a)升高降低小血管卒中风险(OR 0.92)。
  • 遗传预测的Lp(a)升高降低阿尔茨海默病风险(OR 0.94)。

核心结论

  • 高Lp(a)浓度与大动脉粥样硬化性卒中风险增加存在因果关联。
  • 高Lp(a)浓度与小血管卒中及阿尔茨海默病风险降低存在因果关联。
  • Lp(a)对神经系统疾病呈现双刃剑效应,机制待进一步研究。

研究设计与样本

  • 两样本孟德尔随机化研究,使用9个与Lp(a)浓度相关的单核苷酸多态性作为工具变量。
  • 缺血性卒中及其亚型的汇总数据来自Multiancestry Genome-Wide Association Study of Stroke consortium,欧洲个体≤446 696人。
  • 阿尔茨海默病汇总数据来自International Genomics of Alzheimer Project,欧洲个体≤54 162人。
  • 采用逆方差加权、惩罚逆方差加权、简单中位数、加权中位数和MR-PRESSO方法计算MR估计,MR-Egger回归探索多效性。

主要发现

  • 遗传预测的1-SD对数转换Lp(a)升高与大动脉粥样硬化性卒中风险增加相关(OR 1.20;95% CI 1.11-1.30;P<0.001)。
  • 遗传预测的1-SD对数转换Lp(a)升高与小血管卒中风险降低相关(OR 0.92;95% CI 0.88-0.97;P=0.001)。
  • 遗传预测的1-SD对数转换Lp(a)升高与阿尔茨海默病风险降低相关(OR 0.94;95% CI 0.91-0.97;P<0.001)。
  • 总缺血性卒中及心源性栓塞性卒中未观察到显著关联。
  • MR-Egger未提示多效性偏倚,敏感性分析结果 broadly 一致。

临床怎么用

  • 在卒中风险评估中,Lp(a)升高可能提示大动脉粥样硬化性卒中风险增加。
  • Lp(a)升高可能与小血管卒中及阿尔茨海默病风险降低相关,解读时需考虑疾病亚型特异性。
  • 针对Lp(a)的干预策略需权衡其对不同神经系统疾病的相反效应。

局限性

  • 研究基于欧洲人群汇总数据,结果外推至其他种族需谨慎。
  • 孟德尔随机化依赖工具变量假设,虽敏感性分析支持稳健性,仍不能完全排除多效性。
  • Lp(a)对神经系统双刃剑效应的具体机制未在研究中阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Stroke and Alzheimer disease are 2 major causes of neurological disability in aged people and shared overlapping predictors. In recent prospective studies, high Lp(a) [lipoprotein(a)] level is associated with high risk of stroke but low risk of Alzheimer disease. Whether this reflects a causal association remains to be established. The aim of this study is to examine the causal associations of Lp(a) concentrations on ischemic stroke, ischemic stroke subtypes, and Alzheimer disease. Methods- We used 9 single-nucleotide polymorphisms associated with Lp(a) concentrations as instrumental variables. Summary-level data on ischemic stroke and its subtypes were obtained from the Multiancestry Genome-Wide Association Study of Stroke consortium with European individuals ≤446 696 individuals. Summary-level data on Alzheimer disease were obtained from the International Genomics of Alzheimer Project With European individuals ≤54 162 individuals. Two-sample Mendelian randomization (MR) estimates were calculated with inverse-variance weighted, penalized inverse-variance weighted, simple median, weighted median, and MR Pleiotropy Residual Sum and Outlier approaches, and MR-Egger regression was used to explore pleiotropy. Results- Genetically predicted 1-SD log-transformed increase in Lp(a) concentrations was associated with a substantial increase in risk of large artery stroke (odds ratio, 1.20; 95% CI, 1.11-1.30; P<0.001) and a reduce in risk of small vessel stroke (odds ratio, 0.92; 95% CI, 0.88-0.97; P=0.001) and Alzheimer disease (odds ratio, 0.94; 95% CI, 0.91-0.97; P<0.001) using inverse-variance weighted method. No significant association was observed for total ischemic stroke or cardioembolic stroke. MR-Egger indicated no evidence of pleiotropic bias. Results were broadly consistent in sensitivity analyses using penalized inverse-variance weighted, simple median, weighted median, and MR Pleiotropy Residual Sum and Outlier approaches accounting for potential genetic pleiotropy or outliers. Conclusions- This study provides evidence to support that high Lp(a) concentrations was causally associated with an increased risk of large artery stroke but a decreased risk of small vessel stroke and Alzheimer disease. The mechanism underlying the double-edged sword effect of Lp(a) concentrations on neurological system requires further investigation.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Pan Y, Li H, Wang Y, et al. Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer Disease: A Mendelian Randomization Study. Stroke. 2019. PMID: 31597550. doi:10.1161/STROKEAHA.119.026872

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。